Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000031·CYTOKINETICS INC
Schedule 13G ownership disclosure
Cytokinetics Inc
Common Stock · CUSIP: 23282W605
Event date: 2024-12-31
- Filing-level shares
- 11,915,821
- Percent of class
- 10.09%
- The Vanguard Group
Shares: 11,915,821 · Class: 10.09%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000031
- Form type
- SCHEDULE 13G/A
- Filer
- CYTOKINETICS INC
- CIK
- CIK 1061983
- Filed
- Jan 08, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership